eCite Digital Repository
Inflammatory bowel disease
Citation
Jeffrey, EC and Bereznicki, LRE, Inflammatory bowel disease, Australian Pharmacist, 28, (6) pp. 504-509. ISSN 0728-4632 (2009) [Professional, Non Refereed Article]
 | PDF 620Kb |
Official URL: http://www.psa.org.au/?id=4497
Abstract
Inflammatory bowel disease (IBD) refers to a group of
disorders characterised by chronic, relapsing inflammation in
the gut.The main forms of IBD are Cronn's disease (CD) and
ulcerative colitis (UC). The clinical course of both diseases
can range from a mild form, in which the patient reaches
long term remission without taking permanent medication, to
a chronic active form, in which remission is only reached by
permanently taking immunosuppressives and/orbioloqicals.'
Approximately 61,000 Australians have lBO, with 1600new
cases diagnosed each year. 2lBD can bediagnosed at any
age, but has a peak onset between 15to 40years.
Item Details
| Item Type: | Professional, Non Refereed Article |
|---|---|
| Keywords: | inflammatory bowel disease |
| Research Division: | Biomedical and Clinical Sciences |
| Research Group: | Pharmacology and pharmaceutical sciences |
| Research Field: | Clinical pharmacy and pharmacy practice |
| Objective Division: | Health |
| Objective Group: | Clinical health |
| Objective Field: | Clinical health not elsewhere classified |
| UTAS Author: | Jeffrey, EC (Mrs Ella van Tienen) |
| UTAS Author: | Bereznicki, LRE (Professor Luke Bereznicki) |
| ID Code: | 57731 |
| Year Published: | 2009 |
| Deposited By: | Pharmacy |
| Deposited On: | 2009-08-11 |
| Last Modified: | 2010-10-06 |
| Downloads: | 554 View Download Statistics |
Repository Staff Only: item control page